SUBSCRIBE
SUBSCRIBE

Phase I

AstraZeneca PLC Offloads Remaining Anesthetics Portfolio in $766 Million Deal
Drug Development
Investors Wait with Bated Breath for AstraZeneca PLC’s Cancer Trial Data Next Week
September 1, 2017
 · 
3 min read
Incyte Discloses Promising New Data in Combo Drug Trial With Merck & Co.'s Keytruda
Drug Development
Incyte Discloses Promising New Data in Combo Drug Trial With Merck & Co.'s Keytruda
August 31, 2017
 · 
3 min read
Drug Development
How A Potential Drug And A Possible M&A Could Drive Exelixis Even Higher
August 28, 2017
 · 
1 min read
Big-Name Investor Peter Thiel Funds ‘Unethical’ Offshore Herpes Vaccine Trial
Drug Development
Big-Name Investor Peter Thiel Funds ‘Unethical’ Offshore Herpes Vaccine Trial
August 28, 2017
 · 
2 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Drug Development
Biogen Shows Off More Positive Alzheimer’s Trial Data
August 28, 2017
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Drug Development
Biogen Gained $1 Billion Overnight After Becoming Goldman Sachs’ Favorite Biotech
August 17, 2017
 · 
3 min read
Drug Development
How To Try An Experimental Drug When You Don’t Qualify For A Clinical Trial
August 8, 2017
 · 
1 min read
For Sale: Pfizer's $3.4 Billion Consumer Healthcare Business
Drug Development
4 Clinical Projects Shelved From Pfizer’s Pipeline
August 2, 2017
 · 
2 min read
Why This Biotech, Up 300% Since May, Could be the Next Big M&A Target
Drug Development
Massachusetts’ Homology Medicines Snags $83.5M to Advance AMEnDR into Human Trials
August 1, 2017
 · 
2 min read
Ex-Akebia Director Re-arrested After Insider Trading Prosecutors Call Him Unhinged
Drug Development
Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study
July 31, 2017
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Delix Therapeutics Announces Completion of 1st Cohort Dosing, Dose Escalation Approval in Phase I Trial for Novel Compound DLX-001
June 20, 2023
 · 
4 min read
Drug Development
CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma
June 20, 2023
 · 
6 min read
Drug Development
Enanta Pharmaceuticals Announces Positive Data From a Phase 1 Clinical Study of EDP-323, an Oral, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus
June 20, 2023
 · 
7 min read
Drug Development
Minghui Pharmaceutical Inc. Announces First Patient Dosing in Phase 1 Clinical Studies of Both the Antibody-Drug Conjugate Programs Targeting TROP-2 or B7-H3 Respectively, for Treatment of Advanced or Metastatic Solid Tumors
June 20, 2023
 · 
4 min read
Drug Development
Escient Pharmaceuticals Announces Positive Results from Phase 1 Study of EP262, a First-in-Class Oral MRGPRX2 Antagonist for Mast Cell Mediated Disorders
June 20, 2023
 · 
4 min read
Drug Development
Allgenesis Announces Encouraging Phase 1b Data Showing AG-80308 Providing Improvements in Multiple Signs and Symptoms in Dry Eye Patients
June 19, 2023
 · 
2 min read
Drug Development
Chinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy Volunteers and New Insights into the Role of Failed Repair in Chronic Kidney Disease at the 60th European Renal Association (ERA) Congress
June 17, 2023
 · 
11 min read
Drug Development
The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer
June 16, 2023
 · 
4 min read
Drug Development
Defence Manufacturing of AccuTox(TM) CGMP Final Drug Product Optimization for Its Phase I Clinical Trial at City of Hope
June 16, 2023
 · 
3 min read
Drug Development
Mustang Bio Announces Final Results from Follicular Lymphoma Cohort of Single-Institution Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR T Therapy
June 15, 2023
 · 
9 min read
Drug Development
JCRI-ABTS and USMI Reports Statistically Significant Results of the Canady Helios Cold Plasma Phase 1 Clinical Trial on Patients with Stage 4 and Recurrent Advanced Solid Tumors
June 15, 2023
 · 
7 min read
Drug Development
Neurona Therapeutics Presents One-Year Data on the First Patient Treated with NRTX-1001 Cell Therapy in an Ongoing Phase I/II Trial for Drug-resistant Focal Epilepsy
June 15, 2023
 · 
6 min read
Drug Development
Allogene Therapeutics Provides Additional ALLO-501/501A Phase 1 Data in an Oral Presentation at the International Conference on Malignant Lymphoma (ICML) Lugano
June 15, 2023
 · 
9 min read
Drug Development
Pulmatrix Presents PUR3100 Phase 1 Data at the 65th Annual Meeting of the American Headache Society
June 15, 2023
 · 
5 min read
Drug Development
NS Pharma Announces FDA Clearance to Initiate a Phase I/II Study for NS-050/NCNP-03, an Exon 50 Skipping Candidate for the Treatment of Duchenne Muscular Dystrophy
June 15, 2023
 · 
2 min read
Drug Development
Anokion Announces Publication in The Lancet Gastroenterology & Hepatology Highlighting Safety and Preliminary Effects of KAN-101 in Celiac Disease in its ACeD Phase 1 Clinical Trial
June 15, 2023
 · 
3 min read
Drug Development
Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS
June 15, 2023
 · 
4 min read
Drug Development
EyeBio Announces First Patients Dosed in Phase 1b/2 Trial of Restoret™ in Neovascular Age Related Macular Degeneration and Diabetic Macular Edema
June 14, 2023
 · 
5 min read
Drug Development
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China
June 14, 2023
 · 
1 min read
Drug Development
Nurix Therapeutics Presents Data from Studies of Its Targeted Protein Degraders in B Cell Malignancies and Initiates Expansion of NX-2127 Phase 1b Trial in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma Indications
June 14, 2023
 · 
13 min read
Load More